EODData

NASDAQ, GYRE:

19 Sep 2025
LAST:

7.250

CHANGE:
 0.44
OPEN:
7.710
HIGH:
7.710
ASK:
0.000
VOLUME:
603K
CHG(%):
5.72
PREV:
7.690
LOW:
7.110
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Sep 257.7107.7107.1107.250603K
18 Sep 257.6007.7357.4907.69061.2K
17 Sep 257.5907.8707.5107.54059.1K
16 Sep 257.8807.9407.5507.59055K
15 Sep 257.8208.0107.6677.90056.2K
12 Sep 258.1508.2827.8007.83074.9K
11 Sep 258.2308.5558.0458.120167.2K
10 Sep 257.6308.1957.6308.170129.7K
09 Sep 257.9108.0417.6307.67081.4K
08 Sep 257.6607.9607.5507.890111K

COMPANY PROFILE

Name:
About:Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Sector:Healthcare
Industry:Biotechnology
Address:12770 High Bluff Drive, San Diego, CA, United States, 92130
Website:https://www.gyretx.com
CIK:0001124105
ISIN:US4037831033
FIGI:BBG000F88SY8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:376.50
Price to Book:7.43
Price to Sales:6.69
EBITDA:11.46M
Shares:90.83M
Market Cap:658.49M

TECHNICAL INDICATORS

MA5:7.59
MA10:7.77
MA20:7.85
MA50:7.59
MA100:8.22
MA200:9.31
RSI14:42.55
WPR14:-100.00
MTM14:-0.46
ROC14:-0.06
ATR:0.48
Week High:8.28
Week Low:7.11
Month High:8.56
Month Low:7.02
Year High:19.00
Year Low:6.11
Volatility:45.99

RECENT SPLITS

Date Ratio
31 Oct 20231-15
13 Feb 20171-15
21 Aug 20151-7

RECENT DIVIDENDS

Date Amount
13 Jan 2023$3.60
21 Sep 2022$21.45
20 Aug 2015$896.18